The effect of neutrophils on the resistance to anti-VEGF therapy was demonstrated by Jung et al., who showed that the increased neutrophil infiltration after anti-VEGFR2 administration promotes tumor angiogenesis and decreases the efficacy of the therapy [119]. Here, VEGFA is linked to neoplasm.